Related Experiment Videos
Hyperhomocysteinemia decreases bone blood flow
Neetu Tyagi1, Thomas P Vacek, John T Fleming
1Department of Physiology and Biophysics, School of Medicine, University of Louisville, KY, USA. n0tyag01@louisville.edu
Insights
High homocysteine (Hcy) levels, or hyperhomocysteinemia, reduce bone blood flow and compromise bone strength. This study demonstrates Hcy
Area of Science:
- Biomedical Science
- Bone Biology
- Metabolic Disease
Background:
- Elevated plasma homocysteine (Hcy), termed hyperhomocysteinemia (HHcy), is linked to osteoporosis.
- Reduced bone blood flow is a potential mechanism for impaired bone mechanical properties.
Purpose of the Study:
- To investigate the hypothesis that HHcy decreases bone blood flow and biomechanical properties.
- To determine the effect of Hcy on bone blood flow and related biochemical markers in a rat model.
Main Methods:
- Male Sprague-Dawley rats were administered Hcy in drinking water for 8 weeks.
- Measurements included plasma Hcy, vitamin B12, folate, systolic blood pressure, tibial blood flow, and tibial mass.
- Laser Doppler flowmetry was used to assess tibial blood flow.
Main Results:
- Hcy-treated rats exhibited significantly higher Hcy levels and lower vitamin B12 levels compared to controls.
- Tibial blood flow was significantly reduced in Hcy-treated rats (0.51 ± 0.09 flow units) versus controls (0.78 ± 0.09 flow units).
- Tibial mass was reduced in Hcy-treated rats, while bone density remained unchanged.
Conclusions:
- Hcy significantly reduces bone blood flow in rats.
- Reduced bone blood flow due to Hcy may contribute to compromised bone biomechanical properties.
- This suggests a potential mechanism linking HHcy to osteoporosis.
Abstract:
Elevated plasma levels of homocysteine (Hcy), known as hyperhomocysteinemia (HHcy), are associated with osteoporosis. A decrease in bone blood flow is a potential cause of compromised bone mechanical properties. Therefore, we hypothesized that HHcy decreases bone blood flow and biomechanical properties. To test this hypothesis, male Sprague-Dawley rats were treated with Hcy (0.67 g/L) in drinking water for 8 weeks. Age-matched rats served as controls. At the end of the treatment period, the rats were anesthetized. Blood samples were collected from experimental or control rats. Biochemical turnover markers (body weight, Hcy, vitamin B(12), and folate) were measured. Systolic blood pressure was measured from the right carotid artery. Tibia blood flow was measured by laser Doppler flow probe. The results indicated that Hcy levels were significantly higher in the Hcy-treated group than in control rats, whereas vitamin B(12) levels were lower in the Hcy-treated group compared with control rats. There was no significant difference in folate concentration and blood pressure in Hcy-treated versus control rats. The tibial blood flow index of the control group was significantly higher (0.78 ± 0.09 flow unit) compared with the Hcy-treated group (0.51 ± 0.09). The tibial mass was 1.1 ± 0.1 g in the control group and 0.9 ± 0.1 in the Hcy-treated group. The tibia bone density was unchanged in Hcy-treated rats. These results suggest that Hcy causes a reduction in bone blood flow, which contributes to compromised bone biomechanical properties.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Oxygen Transport in the Blood